ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 205 filers reported holding ISIS PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 1.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $19,665,000 | -27.9% | 486,519 | +2.7% | 0.08% | -23.8% |
| Q2 2015 | $27,265,000 | -3.4% | 473,755 | +6.9% | 0.10% | -15.3% |
| Q1 2015 | $28,216,000 | +18.2% | 443,154 | +14.6% | 0.12% | +6.0% |
| Q4 2014 | $23,880,000 | +148.7% | 386,782 | +56.4% | 0.12% | +112.7% |
| Q3 2014 | $9,602,000 | +23.0% | 247,283 | +9.1% | 0.06% | +14.6% |
| Q2 2014 | $7,809,000 | -6.3% | 226,667 | +17.5% | 0.05% | -15.8% |
| Q1 2014 | $8,338,000 | +26.1% | 192,974 | +16.3% | 0.06% | +14.0% |
| Q4 2013 | $6,612,000 | +33.0% | 165,953 | +25.3% | 0.05% | +16.3% |
| Q3 2013 | $4,973,000 | +54.7% | 132,479 | +10.8% | 0.04% | +43.3% |
| Q2 2013 | $3,214,000 | – | 119,610 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 7,202,585 | $270,385,000 | 14.71% |
| DOWLING & YAHNKE LLC | 675,798 | $25,369,000 | 3.98% |
| GARRISON BRADFORD & ASSOCIATES INC | 100,700 | $3,780,000 | 3.87% |
| WILLIAM HARRIS INVESTORS INC | 312,834 | $11,743,000 | 3.67% |
| Meditor Group Ltd | 490,000 | $18,395,000 | 2.59% |
| AVALON CAPITAL MANAGEMENT | 50,943 | $1,912,000 | 1.89% |
| Orinda Asset Management LLC | 14,665 | $551,000 | 1.73% |
| PINNACLE ASSOCIATES LTD | 2,064,760 | $77,511,000 | 1.60% |
| PERKINS CAPITAL MANAGEMENT INC | 52,850 | $1,984,000 | 1.43% |
| NCM Capital Advisers, Inc. | 24,950 | $937,000 | 1.04% |